← Insider buys
RPRX

Royalty Pharma plc · Healthcare

EVP and CFO Terrance P. Coyne sold $2.8M of Royalty Pharma plc

Sold$2,773,956
$39.87Price
69,582Shares
−9%Stake

What RPRX did after the filing

Filed Dec 3Copier in Dec 4
The stock from Thu, Dec 4 open, $39.12
−1.0%
S&P 500, same days
−0.3%

Measured over 30 trading days, to the Jan 20 close.

Traded Mon, Dec 1. Filed Wed, Dec 3, 5:11 PM ET, after the close. Returns use the Dec 4 open and the Jan 20 close. Not investment advice.